Simplex Trading, LLC Inmune Bio, Inc. Transaction History

Simplex Trading, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$7.15 - $11.84 $41,369 - $68,506	5,786 New	5,786 $51,000
Q4 2023 Feb 02, 2024	SELL	$6.6 - $11.52 $65,993 - $115,188	-9,999 Reduced 82.71%	2,090 $23,000
Q3 2023 Nov 01, 2023	BUY	$6.61 - $10.9 $61,466 - $101,359	9,299 Added 333.3%	12,089 $81,000
Q2 2023 Aug 04, 2023	BUY	$6.5 - $10.09 $4,225 - $6,558	650 Added 30.37%	2,790 $25,000
Q1 2023 Apr 27, 2023	SELL	$6.01 - $10.18 $4,008 - $6,790	-667 Reduced 23.76%	2,140 $13,000
Q4 2022 Feb 02, 2023	BUY	$6.13 - $7.96 $3,849 - $4,998	628 Added 28.82%	2,807 $17,000
Q3 2022 Nov 04, 2022	SELL	$6.04 - $10.44 $24,842 - $42,939	-4,113 Reduced 65.37%	2,179 $13,000
Q2 2022 Aug 03, 2022	SELL	$5.48 - $8.97 $92,190 - $150,902	-16,823 Reduced 72.78%	6,292 $55,000
Q1 2022 May 02, 2022	BUY	$6.42 - $11.39 $133,568 - $236,968	20,805 Added 900.65%	23,115 $194,000
Q4 2021 Feb 23, 2022	SELL	$9.97 - $20.38 $50,408 - $103,041	-5,056 Reduced 68.64%	2,310 $23,000
Q3 2021 Oct 28, 2021	BUY	$14.13 - $27.85 $8,478 - $16,710	600 Added 8.87%	7,366 $135,000
Q2 2021 Aug 12, 2021	BUY	$9.29 - $19.33 $62,856 - $130,786	6,766 New	6,766 $118,000

5.88M

243K

46.4K

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $89M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.